Shenogen Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Private

  • Employees
  • 186

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 15

Shenogen General Information

Description

Manufacturer of innovative biopharmaceutical therapeutics intended to advance the discovery, development, and commercialization of novel drugs targeting cancer and immune-related diseases. The company offers a broad pipeline of small molecules, biologics, and targeted therapeutic candidates, backed by proprietary research and global collaborations, enabling patients in oncology and autoimmune care to have improved access to cutting-edge treatment options while addressing unmet medical needs.

Contact Information

Website
www.shenogen.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room 101, 1st Floor, Building 1, Courtyard 15
  • Chuangyi East Second Road, Tongzhou District
  • Beijing, 102206
  • China
+86 010
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Manufacturing, Life Sciences, Oncology
Corporate Office
  • Room 101, 1st Floor, Building 1, Courtyard 15
  • Chuangyi East Second Road, Tongzhou District
  • Beijing, 102206
  • China
+86 010

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Shenogen Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
15. Secondary Transaction - Private 01-Oct-2025 Completed Generating Revenue
14. Later Stage VC 01-Oct-2023 Completed Generating Revenue
13. IPO 16-Dec-2022 Cancelled Generating Revenue
12. Later Stage VC (Series E3) 01-Dec-2019 Completed Generating Revenue
11. Secondary Transaction - Private 26-Sep-2019 Completed Generating Revenue
10. Secondary Transaction - Private 01-Apr-2019 Completed Generating Revenue
9. Later Stage VC (Series E2) 01-Mar-2019 Completed Generating Revenue
8. Secondary Transaction - Private 12-Apr-2018 Completed Generating Revenue
7. Later Stage VC (Series E) 31-Aug-2017 $51M $123M Completed Generating Revenue
6. Later Stage VC (Series D) 29-Jul-2016 $45M $71.8M Completed Generating Revenue
To view Shenogen’s complete valuation and funding history, request access »

Shenogen Patents

  • 63

    Total Documents Applications and Grants

  • Total Patents Families

  • 30

    Granted

  • Pending

  • Expiring in next 12 mo

Shenogen Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2022542585-A Icaritin nanomicelle formulation, its preparation method and its application Active 25-Jul-2019
JP-7386967-B2 Icaritin nanomicelle preparation, its preparation method and its application Active 25-Jul-2019
EP-4005561-A1 Nano-micelle preparation of icaritin and preparation method therefor and application thereof Inactive 25-Jul-2019
EP-4005561-A4 Nano-micelle preparation of icaritin and preparation method therefor and application thereof Inactive 25-Jul-2019
US-20220249370-A1 Nano-micelle preparation of icaritin and preparation method therefor and application thereof Inactive 25-Jul-2019 A61K9/1075
To view Shenogen’s complete patent history, request access »

Shenogen Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Shenogen Investors (15)

Investor Name Investor Type Holding Investor Since Participating Rounds
Fuho Capital Venture Capital Minority
Guangzhou Fund Government Minority
Guangzhou Huacheng Venture Capital Management Growth/Expansion Minority
Huaxi Securities Corporation Minority
New Value Capital (China) Venture Capital Minority
You’re viewing 5 of 15 investors. Get the full list »

Shenogen Investments (1)

Shenogen’s most recent deal was a Later Stage VC with YZY Bio for . The deal was made on 02-Feb-2016.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
YZY Bio 02-Feb-2016 Later Stage VC Pharmaceuticals
To view Shenogen’s complete investments history, request access »

Ready to get started?

Request a free trial

Shenogen FAQs

  • When was Shenogen founded?

    Shenogen was founded in 2006.

  • Where is Shenogen headquartered?

    Shenogen is headquartered in Beijing, China.

  • What is the size of Shenogen?

    Shenogen has 186 total employees.

  • What industry is Shenogen in?

    Shenogen’s primary industry is Drug Discovery.

  • Is Shenogen a private or public company?

    Shenogen is a Private company.

  • What is Shenogen’s current revenue?

    The current revenue for Shenogen is .

  • How much funding has Shenogen raised over time?

    Shenogen has raised $176M.

  • Who are Shenogen’s investors?

    Fuho Capital, Guangzhou Fund, Guangzhou Huacheng Venture Capital Management, Huaxi Securities, and New Value Capital (China) are 5 of 15 investors who have invested in Shenogen.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process